Incidence of mesothelioma In the United States

In 1890 Biggs reported a case of ‘endothelioma’ of the pleura. This report may have been the first recognised case of malignant mesothelioma in North America. Since then the incidence of mesothelioma in North America and the world has steadily climbed.
Studies of the incidence of mesothelioma in North America have been hampered by a paucity of data. Before 1988, the United States did not even have a specific code for mesothelioma, so many cases were misclassified on death certificates as lung cancers or abdominal cancers. In the United States, the best estimates of mesothelioma incidence are derived from the Surveillance, Epidemiology and End Results (SEER) Program of the National Cancer Institute. The SEER database includes about 9.5 per cent of the United States population. It covers 10 regional areas, in five states (Connecticut, Iowa, New Mexico, Utah and Hawaii), and five major urban areas – San Francisco–Oakland, New Orleans, Seattle, Atlanta, and Detroit. Although the SEER regions are reasonably representative of the United States population in terms of demographic and epidemiological factors, the programme may not accurately reflect the country as a whole. It includes some shipbuilding areas, but large urban areas where asbestos was used in manufacturing and construction are underrepresented. The database is organised by case; each case is identified by age, sex, race, date of diagnosis and cancer type. The data for mesothelioma are published only intermittently. However, this database provides the most comprehensive national incidence data available for this disease. In 1997 Price analysed the SEER data for mesothelioma. He divided the data into five-year age groups in each diagnosis year. He found a consistently higher rate of mesothelioma in men than in women. The rate for women remained relatively constant over the years. On the other hand, the rate for men increased until 1992, when it peaked at 1.9 per 100 000 people. Since then the incidence rate in men has been slowly decreasing .This trend is presumably due to occupational asbestos exposure, which was highest during the years 1930–60. The highest lifetime risk was for the 1925–30 birth cohort – a group that would have been at work in shipyards, manufacturing and construction during the years 1930–60. In recent years in the United States, the incidence has beenapproximately 2000–3000 cases per year, or 11.4 cases per million men and 2.8 cases per million women. The mortality rate in people with prolonged heavy exposure to asbestosvaries from 2 to 10 per cent in different studies, and the latency period between initial exposure and manifestation of disease is usually 20–50 years. From 1987 to 1996 an average of 520 people died per year in the United States of malignant mesothelioma. Data from the United States Department of Health and Human Services show that states with the highest incidence of mesothelioma are all coastal or Great Lakes States. Florida has displaced New York as the State with the highest number of deaths per year from mesothelioma. In 1996, 78 people died of mesothelioma in Florida. The states with the highest age-adjusted mortality rates were Washington and Oregon, probably due tothe presence of shipyards. The most frequently recorded occupation on death certificates of people with mesothelioma in the United States was homemaker (10.6 per cent of all deaths), followed by managers and administrators, plumbers, pipefitters and steamfitters,production supervisors, labourers, electricians, farmers, carpenters and machinists. The most common industry was construction, followed by ship building and railroads. Other areas with significant mesothelioma incidence were schools and government.

Mesothelioma life expectancy...

Mesothelioma life expectancy at the time of diagnosis will traditionally be announced at being somewhere between a few months to only a year or two. Statistically speaking, mesothelioma life expectancy is frighteningly short. The mesothelioma life expectancy rate is a mere average, mean or median of mesothelioma patients with wildly different independent variables. Many of these mesothelioma patients have lived years past their expected “date of death” estimate. Mesothelioma treatment and mesothelioma treatment options for these patients differed. Physicians for some patients may have been more experienced than physicians for the less fortunate. Not all patients follow through with chemotherapy or cancer treatment plans upon hearing the low mesothelioma life expectancy statistics, and many are not in shape to handle surgery. But, others fight to live for just one more day.
Survival stories that can affect mesothelioma life expectancy rates range from the rarer cases of a young woman being “cured” – or having no remittance for decades, to the extremes on the other side, an 80+ year old gentleman with lifetime asbestos exposure, smoking heavily and suffering from numerous pre-existing diseases who dies a month after diagnosis. Others die during surgery. Most mesothelioma patient circumstances are somewhere in between. Many mesothelioma sufferers and their life expectancy statistics go unrecorded. Mesothelioma life expectancy will depend on your individual variables, your medical treatment, and your perseverance and outlook. Mesothelioma life expectancy diagnosis will always depend on how early or late the disease was discovered. Because mesothelioma has been largely unrecognized in the past, the bulk of mesothelioma life expectancy statistics are mesothelioma patients who were diagnosed late in the disease. A greater awareness of the disease exists in the medical community, and although the majority of physicians do not have experience treating mesothelioma, most are aware of the potential presence of mesothelioma if a patient has been exposed to asbestos, and can refer a potential mesothelioma patient to a specialist. Early detection and early treatment leads to longer life expectancy. Individuals who have been exposed to asbestos can be pro-active in diagnosing and treating mesothelioma and other asbestos-caused diseases. Patients can monitor their health and mesothelioma symptoms and begin early detection X-ray and CT scan tests. Mesothelioma patients can research mesothelioma treatment options available in clinical trials and discuss these with their physician. A physician can not be aware of every clinical trial that exists, and a mesothelioma patient’s own research could add years on to mesothelioma life expectancy. Statistics for mesothelioma life expectancy will logically improve rather than become worse. Clinical trials on mesothelioma treatment options are increasing with an urgency to halt the disease. Many clinical trial participants live years past the initial diagnosis due to innovative mesothelioma treatment. Others may have participated in a mesothelioma clinical trial that was not as successful, but their participation has cleared the way to successful mesothelioma treatment for others. Chemotherapy and drug combinations have been proven to lengthen mesothelioma life expectancy. Imaging and radiation technology has made significant advances. Mesothelioma life expectancy can pass the low mesothelioma life expectancy rates of the past. Nobody in the statistics of mesothelioma has the identical combination of the physical, emotional, and environmental variables that you do. Medicine advances, it does not go backwards. Mesothelioma treatment and mesothelioma treatment options for your early stage or advanced malignant stage mesothelioma will be up to you. There is a strong chance that you can defy mesothelioma life expectancy statistics. Research. Stay alert to new mesothelioma treatment options. And look at yourself, not statistics.

Blogger Templates by OurBlogTemplates.com 2007